Insider · CIK 0001235862
Leonard E Post
director
Files at QURE (uniQure N.V.), CGON (CG Oncology, Inc.). First filing Dec 6, 2024, latest Sep 17, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 15
$0 bought, $716k sold
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
CGON: CG Oncology, Inc.
CGONOct 9, 2026 · close 63.82
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
QURE: uniQure N.V.
QUREOct 9, 2026 · close 22.59
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 8Weak | CG Oncology, Inc. | $73k 1,000 shares | -100% | - | |
| 6Weak | CG Oncology, Inc. | $41k 1,000 shares | -100% | +165% from low-7% from high | |
| 14Weak | CG Oncology, Inc. | $43k 1,000 shares | -100% | +176% from low-3% from high | |
| 20Weak | CG Oncology, Inc. | $200k 5,000 shares | -100% | +158% from low0% from high | |
| 21Weak | CG Oncology, Inc. | $35k 1,000 shares | -100% | +122% from low-13% from high | |
| 20Weak | CG Oncology, Inc. | $28k 1,000 shares | -100% | +84% from low-28% from high | |
| 7Weak | CG Oncology, Inc. | $56k 2,000 shares | -100% | +83% from low-29% from high | |
| 35Weak | uniQure N.V. | $31k 2,112 shares | -7% | +213% from low-21% from high | |
| 5Weak | CG Oncology, Inc. | $28k 1,000 shares | -100% | +68% from low-34% from high | |
| 5Weak | CG Oncology, Inc. | $31k 1,000 shares | -100% | +79% from low-30% from high | |
| 5Weak | CG Oncology, Inc. | $28k 1,000 shares | -100% | - | |
| 5Weak | CG Oncology, Inc. | $29k 1,000 shares | -100% | - | |
| 5Weak | CG Oncology, Inc. | $30k 1,000 shares | -100% | - | |
| 13Weak | CG Oncology, Inc. | $29k 1,000 shares | -100% | - | |
| 14Weak | CG Oncology, Inc. | $35k 1,000 shares | -100% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 17, 2025 | CGON CG ONCOLOGY INC | 4,000 0.01% of outstanding | $111k | Mar 17, 2025 | $58k |
| Dec 6, 2024 | CGON CG ONCOLOGY INC | 4,000 0.01% of outstanding | $134k | Dec 6, 2024 | none |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | CGON CG Oncology, Inc. | MOption exercise Common Stock10b5-1 | +1,000 | $0.60 | $600 | 1,000 | 25 d ago |
| Sep 15, 2026 | CGON CG Oncology, Inc. | SOpen-market sale Common Stock10b5-1 | -1,000 | $72.98 | $73k | 0 | 25 d ago |
| Sep 15, 2026 | CGON CG Oncology, Inc. | MOption exercise Director Stock Option (right to buy)derivative10b5-1 | -1,000 | $0.00 | $0 | 103,077 | 25 d ago |
| Nov 17, 2025 | CGON CG Oncology, Inc. | MOption exercise Common Stock10b5-1 | +1,000 | $0.60 | $600 | 1,000 | Nov 18, 2025 |
| Nov 17, 2025 | CGON CG Oncology, Inc. | SOpen-market sale Common Stock10b5-1 | -1,000 | $41.43 | $41k | 0 | Nov 18, 2025 |
| Nov 17, 2025 | CGON CG Oncology, Inc. | MOption exercise Director Stock Option (right to buy)derivative10b5-1 | -1,000 | $0.00 | $0 | 117,077 | Nov 18, 2025 |
| Oct 13, 2025 | CGON CG Oncology, Inc. | MOption exercise Common Stock10b5-1 | +1,000 | $0.60 | $600 | 1,000 | Oct 15, 2025 |
| Oct 13, 2025 | CGON CG Oncology, Inc. | SOpen-market sale Common Stock10b5-1 | -1,000 | $43.25 | $43k | 0 | Oct 15, 2025 |
| Oct 13, 2025 | CGON CG Oncology, Inc. | MOption exercise Director Stock Option (right to buy)derivative10b5-1 | -1,000 | $0.00 | $0 | 118,077 | Oct 15, 2025 |
| Sep 30, 2025 | CGON CG Oncology, Inc. | MOption exercise Common Stock10b5-1 | +5,000 | $0.60 | $3,000 | 5,000 | Oct 1, 2025 |
| Sep 30, 2025 | CGON CG Oncology, Inc. | SOpen-market sale Common Stock10b5-1 | -5,000 | $40.09 | $200k | 0 | Oct 1, 2025 |
| Sep 30, 2025 | CGON CG Oncology, Inc. | MOption exercise Director Stock Option (right to buy)derivative10b5-1 | -5,000 | $0.00 | $0 | 119,077 | Oct 1, 2025 |
| Sep 15, 2025 | CGON CG Oncology, Inc. | MOption exercise Common Stock10b5-1 | +1,000 | $0.60 | $600 | 1,000 | Sep 16, 2025 |
| Sep 15, 2025 | CGON CG Oncology, Inc. | SOpen-market sale Common Stock10b5-1 | -1,000 | $35.10 | $35k | 0 | Sep 16, 2025 |
| Sep 15, 2025 | CGON CG Oncology, Inc. | MOption exercise Director Stock Option (right to buy)derivative10b5-1 | -1,000 | $0.00 | $0 | 124,077 | Sep 16, 2025 |
| Sep 3, 2025 | CGON CG Oncology, Inc. | MOption exercise Common Stock10b5-1 | +1,000 | $0.60 | $600 | 1,000 | Sep 4, 2025 |
| Sep 3, 2025 | CGON CG Oncology, Inc. | SOpen-market sale Common Stock10b5-1 | -1,000 | $28.00 | $28k | 0 | Sep 4, 2025 |
| Sep 3, 2025 | CGON CG Oncology, Inc. | MOption exercise Director Stock Option (right to buy)derivative10b5-1 | -1,000 | $0.00 | $0 | 125,077 | Sep 4, 2025 |
| Jul 17, 2025 | CGON CG Oncology, Inc. | MOption exercise Common Stock10b5-1 | +2,000 | $0.60 | $1,200 | 2,000 | Jul 18, 2025 |
| Jul 17, 2025 | CGON CG Oncology, Inc. | SOpen-market sale Common Stock10b5-1 | -2,000 | $28.00 | $56k | 0 | Jul 18, 2025 |
| Jul 17, 2025 | CGON CG Oncology, Inc. | MOption exercise Director Stock Option (right to buy)derivative10b5-1 | -2,000 | $0.00 | $0 | 126,077 | Jul 18, 2025 |
| Jun 20, 2025 | QURE uniQure N.V. | SOpen-market sale Ordinary Shares | -2,112 | $14.45 | $31k | 29,937 | Jun 24, 2025 |
| Jun 11, 2025 | QURE uniQure N.V. | AGrant or award Ordinary Shares | +7,970 | $0.00 | $0 | 32,049 | Jun 13, 2025 |
| Jun 11, 2025 | QURE uniQure N.V. | AGrant or award Stock Option (Right to Buy)derivative | +15,630 | $0.00 | $0 | 15,630 | Jun 13, 2025 |
| Jun 5, 2025 | CGON CG Oncology, Inc. | AGrant or award Director Stock Option (right to buy)derivative10b5-1 | +24,165 | $0.00 | $0 | 24,165 | Jun 6, 2025 |
| May 21, 2025 | CGON CG Oncology, Inc. | MOption exercise Common Stock10b5-1 | +1,000 | $0.60 | $600 | 1,000 | May 22, 2025 |
| May 21, 2025 | CGON CG Oncology, Inc. | SOpen-market sale Common Stock10b5-1 | -1,000 | $28.00 | $28k | 0 | May 22, 2025 |
| May 21, 2025 | CGON CG Oncology, Inc. | MOption exercise Director Stock Option (right to buy)derivative10b5-1 | -1,000 | $0.00 | $0 | 128,077 | May 22, 2025 |
| Apr 28, 2025 | CGON CG Oncology, Inc. | MOption exercise Common Stock10b5-1 | +1,000 | $0.60 | $600 | 1,000 | Apr 29, 2025 |
| Apr 28, 2025 | CGON CG Oncology, Inc. | SOpen-market sale Common Stock10b5-1 | -1,000 | $30.76 | $31k | 0 | Apr 29, 2025 |
| Apr 28, 2025 | CGON CG Oncology, Inc. | MOption exercise Director Stock Option (right to buy)derivative10b5-1 | -1,000 | $0.00 | $0 | 129,077 | Apr 29, 2025 |
| Mar 17, 2025 | CGON CG Oncology, Inc. | MOption exercise Common Stock10b5-1 | +1,000 | $0.60 | $600 | 1,000 | Mar 18, 2025 |
| Mar 17, 2025 | CGON CG Oncology, Inc. | SOpen-market sale Common Stock10b5-1 | -1,000 | $28.00 | $28k | 0 | Mar 18, 2025 |
| Mar 17, 2025 | CGON CG Oncology, Inc. | MOption exercise Director Stock Option (right to buy)derivative10b5-1 | -1,000 | $0.00 | $0 | 130,077 | Mar 18, 2025 |
| Feb 18, 2025 | CGON CG Oncology, Inc. | MOption exercise Common Stock10b5-1 | +1,000 | $0.60 | $600 | 1,000 | Feb 19, 2025 |
| Feb 18, 2025 | CGON CG Oncology, Inc. | SOpen-market sale Common Stock10b5-1 | -1,000 | $28.61 | $29k | 0 | Feb 19, 2025 |
| Feb 18, 2025 | CGON CG Oncology, Inc. | MOption exercise Director Stock Option (right to buy)derivative10b5-1 | -1,000 | $0.00 | $0 | 131,077 | Feb 19, 2025 |
| Jan 13, 2025 | CGON CG Oncology, Inc. | MOption exercise Common Stock10b5-1 | +1,000 | $0.60 | $600 | 1,000 | Jan 14, 2025 |
| Jan 13, 2025 | CGON CG Oncology, Inc. | SOpen-market sale Common Stock10b5-1 | -1,000 | $29.66 | $30k | 0 | Jan 14, 2025 |
| Jan 13, 2025 | CGON CG Oncology, Inc. | MOption exercise Director Stock Option (right to buy)derivative10b5-1 | -1,000 | $0.00 | $0 | 132,077 | Jan 14, 2025 |
| Dec 16, 2024 | CGON CG Oncology, Inc. | MOption exercise Common Stock10b5-1 | +1,000 | $0.60 | $600 | 1,000 | Dec 17, 2024 |
| Dec 16, 2024 | CGON CG Oncology, Inc. | SOpen-market sale Common Stock10b5-1 | -1,000 | $28.84 | $29k | 0 | Dec 17, 2024 |
| Dec 16, 2024 | CGON CG Oncology, Inc. | MOption exercise Stock Optionderivative10b5-1 | -1,000 | $0.00 | $0 | 133,077 | Dec 17, 2024 |
| Dec 6, 2024 | CGON CG Oncology, Inc. | MOption exercise Common Stock10b5-1 | +1,000 | $0.60 | $600 | 1,000 | Dec 6, 2024 |
| Dec 6, 2024 | CGON CG Oncology, Inc. | SOpen-market sale Common Stock10b5-1 | -750 | $34.40 | $26k | 250 | Dec 6, 2024 |
| Dec 6, 2024 | CGON CG Oncology, Inc. | SOpen-market sale Common Stock10b5-1 | -250 | $34.98 | $8,744 | 0 | Dec 6, 2024 |
| Dec 6, 2024 | CGON CG Oncology, Inc. | MOption exercise Stock Optionderivative10b5-1 | -1,000 | $0.00 | $0 | 134,077 | Dec 6, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.